JPH08233801A - Test piece for measuring specific gravity of urine - Google Patents
Test piece for measuring specific gravity of urineInfo
- Publication number
- JPH08233801A JPH08233801A JP6206695A JP6206695A JPH08233801A JP H08233801 A JPH08233801 A JP H08233801A JP 6206695 A JP6206695 A JP 6206695A JP 6206695 A JP6206695 A JP 6206695A JP H08233801 A JPH08233801 A JP H08233801A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- urine
- specific gravity
- test piece
- indicator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 29
- 210000002700 urine Anatomy 0.000 title claims abstract description 29
- 230000005484 gravity Effects 0.000 title claims abstract description 22
- 235000018102 proteins Nutrition 0.000 claims abstract description 38
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 38
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 38
- 239000007793 ph indicator Substances 0.000 claims abstract description 20
- 239000011159 matrix material Substances 0.000 claims abstract description 11
- 239000000872 buffer Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 7
- 108010088751 Albumins Proteins 0.000 claims abstract description 5
- 102000009027 Albumins Human genes 0.000 claims abstract description 5
- 108010076119 Caseins Proteins 0.000 claims abstract description 4
- 108010010803 Gelatin Proteins 0.000 claims abstract description 4
- 239000005018 casein Substances 0.000 claims abstract description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000021240 caseins Nutrition 0.000 claims abstract description 4
- 229920000159 gelatin Polymers 0.000 claims abstract description 4
- 239000008273 gelatin Substances 0.000 claims abstract description 4
- 235000019322 gelatine Nutrition 0.000 claims abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 4
- 108010044091 Globulins Proteins 0.000 claims abstract description 3
- 102000006395 Globulins Human genes 0.000 claims abstract description 3
- 238000005259 measurement Methods 0.000 claims description 6
- 238000005470 impregnation Methods 0.000 abstract description 6
- 238000001035 drying Methods 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 description 17
- 150000001450 anions Chemical class 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 125000003277 amino group Chemical group 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002845 discoloration Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CQBQTNMBPLCAHQ-UHFFFAOYSA-N 1,3-dihydroxypentane-1,3,5-tricarboxylic acid Chemical compound OC(=O)C(O)CC(O)(C(O)=O)CCC(O)=O CQBQTNMBPLCAHQ-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 2
- OBRGVMYQZVQHGO-UHFFFAOYSA-N 3,3-bis(3,5-dibromo-4-hydroxyphenyl)-2-benzofuran-1-one Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2C(=O)O1 OBRGVMYQZVQHGO-UHFFFAOYSA-N 0.000 description 1
- HJTDPDQRTRMIGM-UHFFFAOYSA-N 5-bromo-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound BrC=1C(C(C=CC1)(C)O)C HJTDPDQRTRMIGM-UHFFFAOYSA-N 0.000 description 1
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QPMIVFWZGPTDPN-UHFFFAOYSA-N Tetrabromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C(C(Br)=C(Br)C(Br)=C2Br)=C2S(=O)(=O)O1 QPMIVFWZGPTDPN-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- ABIUHPWEYMSGSR-UHFFFAOYSA-N bromocresol purple Chemical compound BrC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(Br)C(O)=C(C)C=2)=C1 ABIUHPWEYMSGSR-UHFFFAOYSA-N 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
- 229940012189 methyl orange Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- -1 polyethylene terephthalate Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000005353 urine analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、尿中の比重を精度良
く、かつ簡易に測定するための乾式試験片に関するもの
である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a dry test piece for measuring specific gravity in urine accurately and easily.
【0002】[0002]
【従来の技術】尿比重を直接に測定する方法として現在
一般的に行われている方法には、尿比重計、ピクノメー
ター、屈折計などの装置の使用がある。これらの装置
は、ほぼ必要な精度が得られているが、それらの装置は
精度を保持するために、目盛りの校正、器具の洗浄管理
を維持などのメンテナンスが必要であり、時間も手間も
かかり、数多くの不便さがある。2. Description of the Related Art A method currently generally used as a method for directly measuring the specific gravity of urine is the use of a device such as a urine specific gravity meter, a pycnometer, and a refractometer. These devices have achieved almost the required accuracy, but in order to maintain the accuracy, these devices require maintenance such as calibrating the scale and maintaining the cleaning management of the equipment, which takes time and effort. , There are many inconveniences.
【0003】また、測定時において、尿量が一定以上必
要であり、不足する場合も生じる。さらに液面の気泡
や、毛細管現象による目盛りの読み取りの困難さもあ
る。そして、これらの問題を解決したものとして、乾式
の試験紙・試験片タイプの尿比重測定用の乾式試験片が
あり、汎用されつつある。この試験片を尿中に浸漬し、
発色した色を比色表と比較する”dip and re
ad”法で手軽に測定できる上に、他の尿検査項目、例
えばグルコース、ケトン体、蛋白質、ヘモグロビン、白
血球、ビリルビン、ウロビリノーゲン、pH、アスコル
ビン酸等の試験片と組み合わせて、各項目を同時に測定
することができるので非常に便利である。Further, at the time of measurement, the amount of urine needs to be above a certain level and may be insufficient. Furthermore, it is difficult to read the scale due to bubbles on the liquid surface and the capillary phenomenon. As a solution to these problems, there is a dry test strip / test strip type dry test strip for measuring urine specific gravity, which is being widely used. Dip this test piece in urine,
"Dip and re" which compares the developed color with the colorimetric table
It can be easily measured by the "ad" method, and it can be simultaneously measured by combining it with other urine test items such as glucose, ketone bodies, proteins, hemoglobin, white blood cells, bilirubin, urobilinogen, pH, and ascorbic acid. It is very convenient because you can do it.
【0004】試験片に担持させる試薬組成物としては、
特開昭55−101047号公報に見られるごとき、従
来メチルビニルエーテルと無水マレイン酸の共重合物を
水酸化ナトリウムで部分中和した弱電解性ポリマーにp
H指示薬を組合せたものが一般的であった。このタイプ
のものは、試験片と尿検体中へ浸漬した場合、ポリマー
酸基のH+が尿中のカチオン(Na+)とイオン交換して
遊離するからpHが低下し、それがpH指示薬の色の移
動となって測定される。The reagent composition loaded on the test piece is as follows:
As disclosed in JP-A-55-101047, a weak electrolytic polymer obtained by partially neutralizing a conventional copolymer of methyl vinyl ether and maleic anhydride with sodium hydroxide is used.
A combination of H indicators was common. When this type is immersed in a test piece and a urine sample, H + of a polymer acid group is ion-exchanged with a cation (Na + ) in urine to be released, resulting in a decrease in pH, which is a pH indicator. It is measured as a color shift.
【0005】また近時、色調移動の感度と精度を改良す
る手段として、特開平4−315049号公報、特開平
6−294790公報にみられるごとき、試薬組成物な
らびにその含浸試験具が提示されてきた。これらの方法
は、強電解性ポリマーアニオンと解離型色素カチオンと
のイオン会合(結合)が検液のpHに関係なく塩類(N
aCl)の存在に影響を受け、Na+量に対応した色調
移動を生じることに立脚している。Recently, as a means for improving the sensitivity and accuracy of color tone movement, a reagent composition and an impregnation test tool therefor have been proposed as disclosed in JP-A-4-315049 and JP-A-6-294790. It was In these methods, the ionic association (bonding) between the strongly electrolytic polymer anion and the dissociative dye cation does not depend on the pH of the test solution, and the salts (N
It is based on the influence of the presence of aCl) and the color shift corresponding to the amount of Na + .
【0006】[0006]
【発明が解決しようとする課題】尿比重測定用試験片は
“dip and read” 方式の簡便な手段であ
り、臨床段階におけるスクリーニング手段として、実地
医療に不可欠である。しかし、実状は感度、精度におい
てさらに優れた斬新的な手段の開発が常に要請されてい
る。本発明者は鋭意研究を進めてきた一つの成果とし
て、従来の測定原理とは全く異なる新規な原理により、
優れた測定性能を発揮する尿比重測定片の開発に成功
し、本発明を完成するに至った。The urine specific gravity measuring test piece is a simple means of the "dip and read" method, and is indispensable in clinical practice as a screening means in the clinical stage. However, in reality, there is always a demand for the development of innovative means that are more excellent in sensitivity and accuracy. As one result of the inventor's earnest research, a novel principle that is completely different from the conventional measurement principle,
We have succeeded in developing a urine specific gravity measuring piece that exhibits excellent measurement performance, and have completed the present invention.
【0007】[0007]
【発明の開示】本発明は、蛋白質、緩衝剤およびpH指
示薬を含有する含浸液を多孔性マトリックスに吸液さ
せ、乾燥させて作製する尿比重測定用試験片である。こ
の場合、好適には、蛋白質が、アルブミン、グロブリ
ン、ゼラチンまたはカゼインから選ばれるか、またはこ
れらの混合物であること、含浸液中の蛋白質、緩衝剤お
よびpH指示薬の濃度がそれぞれ0.1〜3%(w/
v)、0.05〜2M(モル/l)、および0.1〜2
M(モル/l)であること、さらに多孔性マトリックス
としては濾紙が好適であることを提示するものである。DISCLOSURE OF THE INVENTION The present invention is a urine specific gravity measuring test piece prepared by absorbing an impregnating solution containing a protein, a buffering agent and a pH indicator into a porous matrix and drying the solution. In this case, the protein is preferably selected from albumin, globulin, gelatin or casein, or a mixture thereof, and the concentration of the protein, buffer and pH indicator in the impregnating solution is 0.1 to 3 respectively. % (W /
v), 0.05-2 M (mol / l), and 0.1-2
It suggests that M (mol / l) and that filter paper is suitable as the porous matrix.
【0008】本発明は、尿中の蛋白質を測定する方法と
して一般的に用いられている『蛋白誤差法』が塩濃度の
影響を受けることを逆に利用したものである。すなわち
蛋白質、緩衝剤、pH指示薬の存在下、尿中の陰イオン
とpH指示薬との競争反応を原理とする尿比重測定用乾
式試験片が本発明である。尿分析の分野において、蛋白
質を『蛋白誤差法』を利用して測定する方法は既に公知
である。また、この『蛋白誤差法』が塩濃度、とりわけ
陰イオン(特に塩素イオン)濃度によって影響を受ける
こともまた知られている。これらについては例えば「分
析化学」Vol.42(1993)497〜503頁に
示されている。The present invention makes use of the fact that the "protein error method" generally used as a method for measuring protein in urine is affected by salt concentration. That is, the present invention is a dry test piece for measuring urine specific gravity, which is based on the principle of a competitive reaction between an anion in urine and a pH indicator in the presence of a protein, a buffer and a pH indicator. In the field of urine analysis, methods for measuring proteins using the "protein error method" are already known. It is also known that this "protein error method" is affected by salt concentration, especially anion (especially chloride) concentration. These are described, for example, in “Analytical Chemistry” Vol. 42 (1993) pp. 497-503.
【0009】『蛋白誤差法』では、蛋白質の正荷電した
アミノ基と負荷電したカルボキシル基による電荷的平衡
状態と、pH指示薬における解離型と非解離型による電
荷的平衡状態とがあり、その両者の結合により呈色が見
られる。つまり、蛋白質は、pHが等電点では、電荷的
中性状態であり、正荷電したアミノ基と負荷電したカル
ボキシル基が同数存在する状態にある。pHが等電点以
下では、正荷電したアミノ基が増え、全体として正に荷
電する。逆にpHが等電点以上では、負荷電したカルボ
キシル基が増え、蛋白質は、全体として負に荷電する。
蛋白質は、複数の反応部位を持ち、解離型陰イオンpH
指示薬は、正荷電したアミノ基と結合する。また、尿中
の共存陰イオンも、この正荷電したアミノ基と結合す
る。すなわち、蛋白質の正荷電したアミノ基に、尿中陰
イオンと解離型陰イオンpH指示薬が競争的に反応す
る。The "protein error method" includes a charge equilibrium state due to a positively charged amino group of a protein and a negatively charged carboxyl group, and a charge equilibrium state due to a dissociation type and a non-dissociation type pH indicator. Coloring is seen due to the binding of. That is, the protein is in a charge-neutral state at an isoelectric point of pH, and is in a state in which the same number of positively charged amino groups and negatively charged carboxyl groups are present. When the pH is equal to or lower than the isoelectric point, the number of positively charged amino groups is increased and the whole is positively charged. On the other hand, when the pH is above the isoelectric point, the negatively charged carboxyl groups increase, and the protein is negatively charged as a whole.
Protein has multiple reaction sites, and dissociative anion pH
The indicator binds to the positively charged amino group. Coexisting anions in urine also bind to this positively charged amino group. That is, the urine anion and the dissociative anion pH indicator competitively react with the positively charged amino group of the protein.
【0010】このように尿蛋白の測定法である『蛋白誤
差法』が塩濃度の影響を受けることをふまえて、これが
尿比重の測定法として応用できるかを検討したところ、
意外にも非常に良好な成績が得られた。本発明は、この
『蛋白誤差法』における塩濃度の影響を利用して、尿比
重測定用の試験片を作製しようとするものであ。比重測
定においては、好ましくは蛋白質の正荷電したアミノ基
と解離型陰イオンpH指示薬が結合しやすく、また離れ
やすい状況を設定する。そのためにはpH、蛋白質の等
電点・量・構造・置換基の電荷・分子サイズ、pH指示
薬の量・構造・置換基の電荷・分子サイズなどの適正化
する。Considering that the "protein error method", which is a method for measuring urine protein, is affected by salt concentration, it was examined whether it could be applied as a method for measuring urine specific gravity.
Surprisingly very good results were obtained. The present invention intends to produce a test piece for measuring urine specific gravity by utilizing the influence of salt concentration in the "protein error method". In the measurement of the specific gravity, it is preferable to set a condition in which the positively charged amino group of the protein and the dissociative anion pH indicator are easily bound to each other and easily released. For that purpose, the pH, the isoelectric point / amount / structure / charge of the substituent / molecular size of the protein, and the amount / structure / charge of the substituent / molecular size of the pH indicator are optimized.
【0011】含浸液の作製方法、含浸液の含浸方法、含
浸のための多孔性マトリックスの選択などは従来行われ
ている方法で構わない。すなわち、試薬組成物の溶剤ま
たは分散媒(以下、含浸液用溶媒と略記)としては、水
または/およびアルコール類例えばメタノール、エタノ
ール、イソプロパノール等を使用することができる。ま
た多孔性マトリックスとしては、生理的に、かつ含浸液
用溶媒液に不活性な材質で、重量当たりの表面積が大き
い試薬担持性能を有するものであればいずれも使用する
ことができる。これらの例示としては、天然および合成
になる紙状態、布状態、連続気泡体、粒状体、粒状等各
種のものがあるが、特に、取り扱い易さ、強度、純度の
点から濾紙が好適である。The method of preparing the impregnating liquid, the method of impregnating the impregnating liquid, the selection of the porous matrix for the impregnation, and the like may be conventional methods. That is, water or / and alcohols such as methanol, ethanol, and isopropanol can be used as a solvent or a dispersion medium (hereinafter abbreviated as a solvent for impregnating liquid) of the reagent composition. As the porous matrix, any material can be used as long as it is a material that is physiologically inert to the solvent liquid for the impregnating liquid and has a large surface area per weight and reagent-carrying performance. Examples of these include various types such as natural and synthetic paper states, cloth states, open cells, granules, and granules, and filter paper is particularly preferable from the viewpoint of ease of handling, strength, and purity. .
【0012】使用できる蛋白質の種類としては、アルブ
ミン、α−グロブリン、β−グロブリン、γ−グロブリ
ン、ゼラチン、カゼインなどがあるが、アルブミン、γ
−グロブリンが好適である。蛋白質濃度としては、含浸
液状態で0.1〜3%(w/v)が好ましい。使用でき
る緩衝液の種類としてはクエン酸、リン酸が好適であ
り、濃度としては含浸液状態で0.05〜2M(モル/
1)が好ましい。また、緩衝液のpHは、蛋白質の等電
点以下であればよく、例えば、蛋白質としてアルブミン
を用いた場合、等電点は、4.9であるので、pH3〜
4.5が好ましい。The types of proteins that can be used include albumin, α-globulin, β-globulin, γ-globulin, gelatin and casein.
-Globulin is preferred. The protein concentration is preferably 0.1 to 3% (w / v) in the impregnating liquid state. Citric acid and phosphoric acid are suitable as the type of buffer solution that can be used, and the concentration is 0.05 to 2 M (mol / mol in the impregnating solution state).
1) is preferred. Further, the pH of the buffer solution may be equal to or lower than the isoelectric point of the protein. For example, when albumin is used as the protein, the isoelectric point is 4.9, so that the pH is 3 to
4.5 is preferred.
【0013】使用できるpH指示薬としては、蛋白質の
等電点以下を変色域とするものであれば使用することが
でき、ブロムフェノールブルー、ブロムクレゾールグリ
ーン、ブロムクレゾールパープル、コンゴーレッド、テ
トラブロムフェノールブルー、ブロムキシレノールブル
ー、テトラブロムフェノールフタレイン、メチルオレン
ジなどがあげられ、濃度は、含浸液状態で0.1〜2M
(モル/1)が好ましい。Any pH indicator can be used as long as it has a color change range below the isoelectric point of protein, such as bromphenol blue, bromcresol green, bromcresol purple, congo red and tetrabromophenol blue. , Bromxylenol blue, tetrabromophenolphthalein, methyl orange, etc., and the concentration is 0.1-2M in the impregnating liquid state.
(Mole / 1) is preferable.
【0014】本発明の乾式試験片においては蛋白質、緩
衝剤、pH指示薬をマトリックス層中に含浸・乾燥させ
ると、第1の変色が起こる。pH一定のもと、pH指示
薬に存在する負電荷またはラジカルが蛋白質の正電荷に
近づき、解離型のpH指示薬が生じることにより、pH
指示薬と蛋白質が結合するためと考えられる。そして、
この状態で保存する。In the dry test piece of the present invention, the first discoloration occurs when the protein, the buffer and the pH indicator are impregnated in the matrix layer and dried. At a constant pH, the negative charge or radical present in the pH indicator approaches the positive charge of the protein, and the dissociative pH indicator is generated, which
It is thought that this is because the indicator binds to the protein. And
Save in this state.
【0015】塩を含んだ尿と反応させる場合には、蛋白
質と結合しているpH指示薬と陰イオン(尿ならば特に
塩素イオン)とが競合することにより、第2の変色が起
こる。これは、陰イオン濃度が高くなれば、pH指示薬
が非解離型として蛋白質より遊離するためと思われる。
そしてこの変色を測定する。以下に実施例を示すが、本
発明はこれに限定されるものではない。When reacting with salt-containing urine, a second discoloration occurs due to competition between the pH indicator bound to the protein and anion (especially chloride ion in the case of urine). This is probably because the pH indicator is released from the protein as a non-dissociative type when the anion concentration is high.
And this discoloration is measured. Examples will be shown below, but the present invention is not limited thereto.
【0016】[0016]
含浸液の調製 (処方) ブロムクレゾールグリーン 20mg エタノール 15ml 0.1Mクエン酸緩衝液(pH3.5) 85ml 牛血精アルブミン 100mg 上記の混合物による含浸液を調製した後、15×15c
mの濾紙(ワットマン社製:3MMchr)に含浸し、
50℃にて30分間乾燥する。これを5×5mmに裁断
し、5×60mmの白色ポリエチレンテレフタレートプ
レートの先端に両面テープを用いて貼り付けて、試験片
とした。本発明の尿比重測定用試験片の有用性を示すた
めに上記のようにして作製した試験片を用いて試験を行
った。 試験方法 比重を1.000、1.010、1.020、1.03
0の各レベルに調節した塩化ナトリウム水溶液を調製
し、試料とした。これに先に作製した試験片を2秒間浸
漬し、引き上げた試験片の呈色を目視で観察し、同時に
色差計((株)日本電色工業、Σ−90)で620nm
での反射率を測定した。 試験結果 試験結果を表1に示す。Preparation of Impregnation Solution (Prescription) Bromcresol Green 20 mg Ethanol 15 ml 0.1 M Citrate Buffer (pH 3.5) 85 ml Bovine Serum Albumin 100 mg After preparing the impregnation solution with the above mixture, 15 × 15 c
m filter paper (manufactured by Whatman: 3MMchr)
Dry at 50 ° C. for 30 minutes. This was cut into 5 × 5 mm and attached to the tip of a 5 × 60 mm white polyethylene terephthalate plate using a double-sided tape to give a test piece. In order to show the usefulness of the test piece for measuring urine specific gravity of the present invention, a test was conducted using the test piece prepared as described above. Test method Specific gravity 1.000, 1.010, 1.020, 1.03
A sodium chloride aqueous solution adjusted to each level of 0 was prepared and used as a sample. The test piece previously prepared was immersed in this for 2 seconds, and the color of the pulled-up test piece was visually observed, and at the same time, it was measured with a color difference meter (Nippon Denshoku Industries Co., Ltd., Σ-90) at 620 nm
The reflectance at was measured. Test results The test results are shown in Table 1.
【0017】[0017]
【表1】 表1の比重値と色差計による反射率との関係を表2に示
す。供試水溶液の比重と反射率は、良好な比例関係にあ
ることが判る。[Table 1] Table 2 shows the relationship between the specific gravity value in Table 1 and the reflectance measured by a color difference meter. It can be seen that the specific gravity and reflectance of the test aqueous solution have a good proportional relationship.
【0018】[0018]
【表2】 [Table 2]
【0019】[0019]
【発明の効果】本発明は従来の原理とは全く異なる原理
に基づいており、本発明によれば良好な測定結果を示す
新しい尿比重測定試験紙が得られる。The present invention is based on a principle completely different from the conventional principle, and according to the present invention, a new urine specific gravity measuring test paper showing a good measurement result can be obtained.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 山口 武広 京都市南区東九条西明田町57番地 株式会 社京都第一科学内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Takehiro Yamaguchi 57, Higashikujo Nishi-Ameracho, Minami-ku, Kyoto City Stock Company Kyoto Daiichi Kagaku
Claims (3)
する含浸液を多孔性マトリックスに吸液させ、乾燥させ
て作製する尿比重測定用試験片。1. A test piece for measuring urine specific gravity, which is produced by allowing an impregnating solution containing a protein, a buffer and a pH indicator to be absorbed in a porous matrix and then dried.
チンまたはカゼインから選ばれるか、またはこれらの混
合物であることを特徴とする請求項1の尿比重測定用試
験片。2. The test piece for measuring urine specific gravity according to claim 1, wherein the protein is selected from albumin, globulin, gelatin, and casein, or a mixture thereof.
示薬の濃度がそれぞれ0.1〜3%(w/v)、0.0
5〜2M(モル/l)、および0.1〜2M(モル/
l)である請求項1〜2の尿比重測定用試験片。3. The concentration of protein, buffer and pH indicator in the impregnating solution is 0.1 to 3% (w / v) and 0.0, respectively.
5-2M (mol / l), and 0.1-2M (mol / l)
The test piece for urine specific gravity measurement according to claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6206695A JPH08233801A (en) | 1995-02-23 | 1995-02-23 | Test piece for measuring specific gravity of urine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6206695A JPH08233801A (en) | 1995-02-23 | 1995-02-23 | Test piece for measuring specific gravity of urine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08233801A true JPH08233801A (en) | 1996-09-13 |
Family
ID=13189368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6206695A Pending JPH08233801A (en) | 1995-02-23 | 1995-02-23 | Test piece for measuring specific gravity of urine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH08233801A (en) |
-
1995
- 1995-02-23 JP JP6206695A patent/JPH08233801A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rodkey | Direct spectrophotometric determination of albumin in human serum | |
| US5403744A (en) | Method, composition and device for measuring the ionic strength or specific gravity of a test sample | |
| EP0345582B1 (en) | Composition and method of assaying for trace amounts of proteins | |
| US3485587A (en) | Protein indicator | |
| US5302531A (en) | Composition for the semiquantitative determination of specific gravity of a test sample | |
| JP2519102B2 (en) | Compositions and methods for testing aqueous liquids for specific gravity | |
| CA2152413C (en) | Dry reagent for creatinine assay | |
| JPH0650315B2 (en) | Immunological analysis reagent and immunological analysis method | |
| US5858788A (en) | Reagent for determining the ionic strength and/or the specific weight of aqueous liquids, and method | |
| US5087575A (en) | Composition for determining trace amount of protein | |
| JP2657966B2 (en) | Improved method for depositing metal particles on markers | |
| JP3516012B2 (en) | Composition for measuring trace amounts of protein | |
| US5593895A (en) | Method for the detection of protein in urine | |
| US4230601A (en) | Calibrator composition based upon dialyzed blood serum | |
| JPH029310B2 (en) | ||
| US3095277A (en) | Diagnostic composition | |
| US4230456A (en) | Element and assay for albumin | |
| AU607767B2 (en) | Method for the determination of albumin in biological fluids | |
| JPH08233801A (en) | Test piece for measuring specific gravity of urine | |
| JPH043828B2 (en) | ||
| JPS5885163A (en) | Integrated multi-layer analysing element for analysis of protein | |
| JP2522970B2 (en) | Test piece for determination of creatinine in body fluid and method for producing the same | |
| JP2632989B2 (en) | Method for measuring unsaturated iron binding ability | |
| JP2522971B2 (en) | Creatinine quantification test piece and its manufacturing method | |
| JPH0575069B2 (en) |